Biotechnology Newswire
Array BioPharma to Present at the Piper Jaffray Health Care Conference
BOULDER, Colo.-(Business Wire)-November 20, 2008 -
Luminex Corporation and Mingyuan Medicare Development Company Sign Distribution Agreement
AUSTIN, Texas & HONG KONG-(Business Wire)-November 20, 2008 -
Vienna to Host BIO-Europe 2009
ZURICH, Switzerland & CARLSBAD, Calif. & VIENNA, Austria-(Business Wire)-November 20, 2008 -
Geospiza Acquires Award-Winning GeneSifter® Data Analysis Product
SEATTLE-(Business Wire)-November 20, 2008 -
TruthAboutProbiotics.com Helps Separate Fact From Fiction
WESTLAKE VILLAGE, Calif.-(Business Wire)-November 20, 2008 -
OSI Pharmaceuticals to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008
MELVILLE, N.Y.-(Business Wire)-November 20, 2008 -
BioReliance Announces First Commercial Use of HyMy™ Assay
ROCKVILLE, Md.-(Business Wire)-November 20, 2008 -
Thirteenth Annual MITX Awards Recognize the Best Interactive Technology and Web Achievements of New England Companies
CAMBRIDGE, Mass.-(Business Wire)-November 20, 2008 -
Gloucester Pharmaceuticals to Present Positive Results from Multiple Romidepsin Clinical Trials at the ASH Annual Meeting
CAMBRIDGE, Mass.-(Business Wire)-November 20, 2008 -
WaveMark and LUMEDX Partner to Provide Integrated RFID-Enabled Solution to Streamline the Healthcare Supply Chain and Improve Clinical Workflow
LITTLETON, Mass. & OAKLAND, Calif.-(Business Wire)-November 20, 2008 -
Adimab, Inc. Announces Series C Financing
LEBANON, N.H.-(Business Wire)-November 20, 2008 -
Thought Leaders from Burzynski Research Institute, Inc. Present Encouraging Data on Antineoplastons for Treatment of Malignant Gliomas
HOUSTON & LAS VEGAS-(Business Wire)-November 20, 2008 -
Provectus Lead Investigator Professor John F. Thompson Gives Update on PV-10 Melanoma Study at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting
KNOXVILLE, Tenn.-(Business Wire)-November 20, 2008 -
Morphotek®, Inc. Receives Additional $1.6M in Funding from The U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons
EXTON, Pa.-(Business Wire)-November 20, 2008 -
Targacept Scientists Make Multiple Presentations at Society for Neuroscience Supporting the Potential of NNR Therapeutics to Treat CNS Diseases and Disorders
WINSTON-SALEM, N.C.-(Business Wire)-November 20, 2008 -
PharmaNet Development Group Announces Exchange Offer for Its Outstanding 2.25% Convertible Senior Notes Due 2024
PRINCETON, N.J.-(Business Wire)-November 20, 2008 -
Cook Medical’s Aortic Intervention Division Builds On Success With Innovative, New Minimally Invasive Treatments for Aortic Diseases
NEW YORK-(Business Wire)-November 20, 2008 -
LifeCycle Pharma A/S to Host Conference Call Announcing Interim Results for the Third Quarter of 2008
HØRSHOLM, Denmark-(Business Wire)-November 20, 2008 -
Ardea Biosciences to Present at the 20th Annual Piper Jaffray Healthcare Conference
SAN DIEGO-(Business Wire)-November 20, 2008 -
National Neurovision Research Institute (NNRI) and Resolvyx Pharmaceuticals Collaborate to Assess Resolvins to Treat Degenerative Eye Diseases
OWINGS MILLS, Md. & BEDFORD, Mass.-(Business Wire)-November 20, 2008 -
Resolvyx Announces Open IND for RX-10045, the Lead Resolvin Therapeutic for Dry Eye
BEDFORD, Mass.-(Business Wire)-November 20, 2008 -
Invitrogen and Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration
CARLSBAD, Calif. & NORWALK, Conn.-(Business Wire)-November 20, 2008 -
Clinical Data Participates in MAb IMPACT Meeting to Improve Clinical Efficacy of Monoclonal Antibodies for Cancer Treatment
NEWTON, Mass.-(Business Wire)-November 20, 2008 -
Cougar Biotechnology Announces Initiation of Phase I/II Trial of CB7630 (Abiraterone Acetate) in Advanced Breast Cancer Patients
LOS ANGELES-(Business Wire)-November 20, 2008 -
Whole Foods Market® Selects the Institute for Marketecology (IMO) as One of Three Certifiers for Whole Trade Guarantee Program
SAN FRANCISCO-(Business Wire)-November 20, 2008 -
CaridianBCT Launches Mononuclear Cell Collection Protocol
LAKEWOOD, Colo.-(Business Wire)-November 20, 2008 -
Letter to Digital Angel Stockholders from CEO Joseph J. Grillo
SOUTH ST. PAUL, Minn.-(Business Wire)-November 20, 2008 -
Dr. Etienne Gagnon Receives CIHR BIOTECanada/Schering-Plough Canada Fellowship for Innovative Cancer Research
OTTAWA-(Business Wire)-November 20, 2008 -
Affymax Announces Another Favorable Data Monitoring Committee Review of Phase 3 Hematide Program
PALO ALTO, Calif.-(Business Wire)-November 20, 2008 -
Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program
CAMBRIDGE, Mass.-(Business Wire)-November 20, 2008 -
Life Sciences Discovery Fund Announces 2009 Grant Competitions
SEATTLE-(Business Wire)-November 20, 2008 -
Open-source Analysis Tool enables Rapid Annotation of Metagenomes
BRANFORD, Conn.-(Business Wire)-November 20, 2008 -
Synta Pharmaceuticals Announces First Patient Treated in Phase 1/2 Clinical Trial of Elesclomol in Prostate Cancer
LEXINGTON, Mass.-(Business Wire)-November 20, 2008 -
Idera Pharmaceuticals and Merck & Co., Inc. Extend Research Collaboration for Agonists of Toll-like Receptors
CAMBRIDGE, Mass.-(Business Wire)-November 20, 2008 -
Dr. Elaine Mardis Joins Pacific Biosciences Scientific Advisory Board
MENLO PARK, Calif.-(Business Wire)-November 20, 2008 -
Learn about the World Molecular Diagnostics Market
NEW YORK-(Business Wire)-November 20, 2008 -
Pro-Pharmaceuticals Files Registration Statement for Rights Offering to Its Shareholders
NEWTON, Mass.-(Business Wire)-November 20, 2008 -
USAU Scans Potential Acquisition
LAS VEGAS-(Business Wire)-November 20, 2008 -
ImClone Systems’ State-of-the-Art Manufacturing Facility Receives FDA Approval for Multi-Product Biologics Production
NEW YORK-(Business Wire)-November 20, 2008 -
Lumidigm Biometric Sensor Included in Popular Science Best of What’s New for 2008
ALBUQUERQUE, N.M.-(Business Wire)-November 20, 2008 -
Teva Provides Update on Generic Pulmicort Respules® Launch
JERUSALEM-(Business Wire)-November 20, 2008 -
Carlos V. Paya, MD, PhD, to Join Elan as Company President
DUBLIN, Ireland & SAN FRANCISCO & NEW YORK-(Business Wire)-November 20, 2008 -
BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Letters
ALAMEDA, Calif.-(Business Wire)-November 20, 2008 -
FDA Advisory Committee Provides Opinion on Oritavancin for the Treatment of Complicated Skin and Skin Structure Infections
CAMBRIDGE, Mass.-(Business Wire)-November 20, 2008 -
BIO Congratulates Former Senator Tom Daschle on His Nomination to Serve as HHS Secretary
WASHINGTON-(Business Wire)-November 19, 2008 -
BIO Thanks Senators for Supporting a Sound Scientific Review in Renewable Fuel Standard Rule
WASHINGTON-(Business Wire)-November 19, 2008 -
Charles River Promotes Foster Jordan to Corporate Senior Vice President
WILMINGTON, Mass.-(Business Wire)-November 19, 2008 -
Invitrogen Launches In Vivo RNAi Delivery Reagent
CARLSBAD, Calif.-(Business Wire)-November 19, 2008 -
Gentium Provides an Update on the Phase 3 Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
VILLA GUARDIA, Italy-(Business Wire)-November 19, 2008 -
Acquisition Stake with Molecular Vision Completed; Acrongenomics Enters a New Era
LONDON-(Business Wire)-November 19, 2008 -
“Potential Game-Changing” Confocal Technology Opening Eyes
MONTVALE, N.J.-(Business Wire)-November 19, 2008 -
BioDelivery Sciences Remains on Schedule for December ONSOLIS Resubmission Following Meeting with FDA
RALEIGH, N.C.-(Business Wire)-November 19, 2008 -
Covidien Launches Improved Magellan Safety Hypodermic Needle
MANSFIELD, Mass.-(Business Wire)-November 19, 2008 -
TaconicArtemis Announces Publication in PNAS: Inducible Gene Silencing in Transgenic Rats via RNAi
COLOGNE, Germany-(Business Wire)-November 19, 2008 -
Power3 Medical Files Two CIP Patent Applications for BC-SeraPro Breast Cancer Blood Test and Biomarkers
HOUSTON-(Business Wire)-November 19, 2008 -
Quintiles, SAS Announce Development of First-Ever Clinical Trials Statistical Programming Certification
RESEARCH TRIANGLE PARK & CARY, N.C.-(Business Wire)-November 19, 2008 -
Nymox Announces NEXUS-1 and NEXUS-2 Phase 3 Trials for NX-1207 Investigational Drug for BPH
HASBROUCK HEIGHTS, N.J.-(Business Wire)-November 19, 2008 -
Research and Markets: Drug Target Analytical Report: HCRTR1 - An Insight into Pathways, Disease Associations, Competitive Landscape, Chemotypes, Discovery Pipeline, and Marketed Drugs
DUBLIN, Ireland-(Business Wire)-November 19, 2008 -
KAI Reports Positive Preclinical Results for KAI-1678, First-in-Class Compound to Treat Pain
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-November 19, 2008 -
ProTrials Wins Stevie® Award For Women In Business
MOUNTAIN VIEW, Calif. & NEW YORK-(Business Wire)-November 19, 2008 -
Research and Markets: This Global Research Report in Medicine and Biology Nanoscience and Nanotechnology is Now Available
DUBLIN, Ireland-(Business Wire)-November 19, 2008 -
Konstantinos Andrikopoulos, Ph.D., J.D., Joins RXi Pharmaceuticals as VP, Legal Counsel & Chief IP Counsel
WORCESTER, Mass.-(Business Wire)-November 19, 2008 -
Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings
NEW YORK-(Business Wire)-November 19, 2008 -
Safeguard Scientifics Participates in Follow-On Series C Equity Financing for Tengion, Inc.
WAYNE, Pa.-(Business Wire)-November 19, 2008 -
Medtronic Launches New Medical Device in U.S. to Improve Treatment of Aortic Aneurysms
MINNEAPOLIS-(Business Wire)-November 19, 2008 -
Roche NimbleGen Launches CGH 12x135K Microarrays for Detection of Copy Number Variation
MADISON, Wis.-(Business Wire)-November 19, 2008 -
Inhibiton Therapeutics Announces the Addition of Aaron A. Grunfeld to Its Board of Directors
CENTENNIAL, Colo.-(Business Wire)-November 19, 2008 -
Medtronic to Showcase Latest Aortic Repair Technology at International Vascular Surgery Meeting in New York
MINNEAPOLIS-(Business Wire)-November 19, 2008 -
Arrowhead CEO Provides Update on Tego Biosciences Corporation
PASADENA, Calif.-(Business Wire)-November 19, 2008 -
Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
NEW YORK-(Business Wire)-November 19, 2008 -
GenVec Announces Interim Survival Data in Pivotal Trial of TNFerade™ in Locally Advanced Pancreatic Cancer
GAITHERSBURG, Md.-(Business Wire)-November 19, 2008 -
Titan Pharmaceuticals Presents Phase 3 Data for Probuphine® at the 2008 International Society of Addiction Medicine Congress
SOUTH SAN FRANCISCO, Calif & CAPE TOWN, South Africa-(Business Wire)-November 19, 2008 -
Knopp Neurosciences Completes Series B2 Financing, Raising Total Capitalization to $27 Million
PITTSBURGH-(Business Wire)-November 19, 2008 -
Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals, Inc.
SAN MARINO, Calif.-(Business Wire)-November 19, 2008 -
Teva Receives First U.S. Approval for Generic Pulmicort Respules®; Commences Commercial Launch
JERUSALEM-(Business Wire)-November 19, 2008 -
Teva Announces Agreement on Allegra® Patent Challenge
JERUSALEM-(Business Wire)-November 19, 2008 -
Washington State’s Leading Life Sciences Organization Names New President
SEATTLE-(Business Wire)-November 19, 2008 -
Introgen Announces the Transfer of its Listing of Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market
AUSTIN, Texas-(Business Wire)-November 18, 2008 -
Emergent BioSolutions to Webcast Presentation at the 6th Annual Southwestern Showcase Investor Conference on November 20, 2008
ROCKVILLE, Md.-(Business Wire)-November 18, 2008 -
NitroMed and Archemix Announce Merger Agreement
LEXINGTON, Mass. & CAMBRIDGE, Mass.-(Business Wire)-November 18, 2008 -
ArthroCare Receives Expected Additional NASDAQ Staff Determination Letter Regarding Delayed Filing of Form 10-Q; NASDAQ Panel Decision Remains Pending
AUSTIN, Texas-(Business Wire)-November 18, 2008 -
ReGen Biologics Collagen Scaffold Receives Positive Orthopaedic Panel Recommendations
HACKENSACK, N.J.-(Business Wire)-November 18, 2008 -
Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
HONOLULU-(Business Wire)-November 18, 2008 -
BioSphere’s UFE Awareness Campaign Continues with NBC-TV “Today” Show Appearance by Beverly Johnson
ROCKLAND, Mass.-(Business Wire)-November 18, 2008 -
New Study Highlights Rising Number of Type 2 Diabetes Patients in U.S., Increasing Complexity of Treatments
NORWALK, Conn.-(Business Wire)-November 18, 2008 -
BloodCenter of Wisconsin Names Roger D. Klein, M.D., J.D., Medical Director, Molecular Oncology
MILWAUKEE-(Business Wire)-November 18, 2008 -
Patient Enrollment Begins in Exploratory Phase II Trial of NovaBay's Lead Aganocide Compound, NVC-422, in Catheter-Associated Urinary Tract Infections
EMERYVILLE, Calif.-(Business Wire)-November 18, 2008 -
Clinical Presentations on Synchrony® IOL Receive Top Honors at Annual Meeting of American Academy of Ophthalmology
IRVINE, Calif.-(Business Wire)-November 18, 2008 -
Children’s Hospital Boston Selects Geospiza’s FinchLab for SOLiD
SEATTLE-(Business Wire)-November 18, 2008 -
GE Healthcare Announces Three Groundbreaking Digital Programs with Leading Medical Institutions
NEW YORK-(Business Wire)-November 18, 2008 -
CytoGenix, Inc. Board Appoints Industry Veteran Lex M. Cowsert, PhD as President, Chief Executive Officer and Director
HOUSTON-(Business Wire)-November 18, 2008 -
Economist Finds Flaws in 14-Year Data Exclusivity Claim for Biogenerics
WASHINGTON-(Business Wire)-November 18, 2008 -
Understand How U.S. Pharmaceutical and Biotechnology Organizations Can Optimize Their CI Operations While Working Within Defined Guidelines
DUBLIN, Ireland-(Business Wire)-November 18, 2008 -
New Publication Shows Angiomax Significantly Reduces Initial Hospital Costs by $572 Per Patient Compared to Conventional Therapy in Moderate and High-Risk ACS Patients
PARSIPPANY, N.J.-(Business Wire)-November 18, 2008 -
Aethlon Medical Releases Shareholder Letter
SAN DIEGO-(Business Wire)-November 18, 2008 -
NeurAxon, Inc. to Present at 20th Annual Piper Jaffray Health Care Conference December 2, 2008
WALTHAM, Mass.-(Business Wire)-November 18, 2008 -
dLife and WellDoc Partner to Bring Innovative Solution to Diabetes Patients
BALTIMORE-(Business Wire)-November 18, 2008 -
SEBIO Announces Four Finalists Selected in 2nd Annual BIO/Plan Competition; Finalists to Present at Upcoming Investor Forum
ATLANTA-(Business Wire)-November 18, 2008 -
Mintz Levin Represents Genelabs Technologies in $57M Deal with GlaxoSmithKline
BOSTON-(Business Wire)-November 18, 2008 -
Blue Vector Opens Platform to Third-Party Developers
PALO ALTO, Calif.-(Business Wire)-November 18, 2008 -
Immunosyn Corporation Files 10-Q
LA JOLLA, Calif.-(Business Wire)-November 18, 2008 -
Aperio Receives Second FDA Clearance for Diagnosis of Digital Breast Cancer Slides
VISTA, Calif.-(Business Wire)-November 18, 2008 -
Halloran Consulting Group Appoints Industry Veterans in Quality Systems and Training Practice Areas
BOSTON-(Business Wire)-November 18, 2008 -
New Data in Journal Obesity Demonstrate that a Noninvasive, Removable Medical Device Results in Substantial Weight Loss and Glucose Normalization in a Preclinical Model of Obesity
LEXINGTON, Mass.-(Business Wire)-November 18, 2008 -
Learn about the World Biotechnology Market Brief
NEW YORK-(Business Wire)-November 18, 2008 -
The Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
RESEARCH TRIANGLE PARK, N.C. & MIAMI-(Business Wire)-November 18, 2008 -
XDx to Present at the 2008 In Vitro Diagnostic Regulatory and Reimbursement Conference
BRISBANE, Calif.-(Business Wire)-November 18, 2008 -
QC Sciences™ Announces Innovative Solution to Reduce Laboratory Costs
NASHVILLE, Tenn.-(Business Wire)-November 18, 2008 -
The International Myeloma Foundation Announces New Three-Way Research Agreement with Nobel Prize Winner Luc Montagnier and Howard Urnovitz of Chronix Biomedical
NORTH HOLLYWOOD, Calif.-(Business Wire)-November 18, 2008 -
Geron Corporation to Present at Lazard Capital Markets Healthcare Conference
MENLO PARK, Calif.-(Business Wire)-November 18, 2008 -
Provectus Lead Investigator Professor John F. Thompson to Present at Clinical Oncological Society of Australia 2008 Annual Scientific Meeting on November 19, 2008
KNOXVILLE, Tenn.-(Business Wire)-November 18, 2008 -
StemCells, Inc. Closes $20 Million Equity Financing
PALO ALTO, Calif.-(Business Wire)-November 18, 2008 -
New Imaging Technique Tracks Cancer-Killing Cells over Prolonged Period in First-Ever Stanford Case Study
STANFORD, Calif.-(Business Wire)-November 18, 2008 -
Catalent Introduces the Secure-Vial™ Technology for Innovative and Cost Effective Delivery of Injectable Pharmaceuticals
SOMERSET, N.J.-(Business Wire)-November 18, 2008 -
Lilly Selects ICON to Manage its Clinical Data Management Business Outside the US
DUBLIN, Ireland-(Business Wire)-November 18, 2008 -
NuGEN Expands Executive Team With Finance and Marketing Pros
SAN CARLOS, Calif.-(Business Wire)-November 18, 2008 -
Lumidigm / Innometriks Biometric Reader Passes TSA Evaluation for TWIC Pilot
ALBUQUERQUE, N.M. and FALLBROOK, Calif.-(Business Wire)-November 18, 2008 -
Revance Secures $8 Million in New Financing
NEWARK, Calif.-(Business Wire)-November 18, 2008 -
Numerate Completes $4 Million Financing
SAN BRUNO, Calif.-(Business Wire)-November 18, 2008 -
Teva Completes Enrollment in Laquinimod Phase III Clinical Trial
JERUSALEM & LUND, Sweden-(Business Wire)-November 18, 2008 -
Genentech Issues Dear Healthcare Provider Letter Regarding a 2nd Case of PML in a Raptiva Patient
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-November 17, 2008 -
Celgene Corporation to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
SUMMIT, N.J.-(Business Wire)-November 17, 2008 -
Genzyme and the International Center for Genetic Engineering and Biotechnology Form Collaboration to Advance Treatments for Neglected Diseases
CAMBRIDGE, Mass. & TRIESTE, Italy-(Business Wire)-November 17, 2008 -
Acusphere, Inc. Announces Resignation of Howard Bernstein
WATERTOWN, Mass.-(Business Wire)-November 17, 2008 -
Lead Integrity Alert™ Shown to Reduce Unnecessary Shocks
MINNEAPOLIS-(Business Wire)-November 17, 2008 -
Averion International Reports 2008 Third Quarter Financial Results
SOUTHBOROUGH, Mass.-(Business Wire)-November 17, 2008 -
Celprogen Introduces an in vivo Model for Human Brain Cancer (Human Glioblastoma GBM) for Drug Discovery Applications
SAN PEDRO, Calif.-(Business Wire)-November 17, 2008 -
Maas Biolab Scientists Validate Cyclosporin Human Neuroprotection
ALBUQUERQUE, N.M.-(Business Wire)-November 17, 2008 -
ViraCor Laboratories Helps Hospitals Effectively Navigate Impending Flu Season
KANSAS CITY, Mo.-(Business Wire)-November 17, 2008 -
Fluidigm’s Third Quarter Product Revenue Triples
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-November 17, 2008 -
Bio-Path Holdings, Inc. Announces the Signing of a Drug Manufacturing Agreement with Althea Technologies, Inc.
HOUSTON-(Business Wire)-November 17, 2008 -
Targanta Announces Posting of Briefing Documents for Review of FDA Anti-Infective Drugs Advisory Committee Meeting for Oritavancin
CAMBRIDGE, Mass.-(Business Wire)-November 17, 2008 -
Clinilabs Appoints Senior Medical Director of Clinical Pharmacology Unit (CPU)
NEW YORK-(Business Wire)-November 17, 2008 -
BIO International Convention Named 2008 Top Association Show by Tradeshow Week
WASHINGTON-(Business Wire)-November 17, 2008 -
World's Most Prominent Pharmaceutical Scientists to Present Studies Shaping the Industry’s Future
ATLANTA-(Business Wire)-November 17, 2008 -
Sorin Group and Sphere Medical Sign an Agreement to Apply Microsensor Technology in the Field of Cardiopulmonary Bypass
MILAN, Italy & CAMBRIDGE, UK-(Business Wire)-November 17, 2008 -
Advanced Cell Technology Comments on Technology Platform
WORCESTER, Mass.-(Business Wire)-November 17, 2008 -
Millipore Corporation Introduces First Bioplastic Product
BILLERICA, Mass.-(Business Wire)-November 17, 2008 -
NeuroNexus Technologies and Philips Partner to Research Next-Generation Deep Brain Stimulation Devices for the Treatment of Central Nervous System Disorders
EINDHOVEN, Netherlands-(Business Wire)-November 17, 2008 -
RadarFind Wins Technology Award
MORRISVILLE, N.C.-(Business Wire)-November 17, 2008 -
L Capital Partners Leads $3 Million Financing of Evogen
NEW YORK-(Business Wire)-November 17, 2008 -
Webcast Alert: Lpath Third Quarter Business Review Teleconference
SAN DIEGO-(Business Wire)-November 17, 2008 -
New Certification in Medical Publications Planning Reinforces Professional Credibility and Integrity
BRIARCLIFF MANOR, N.Y.-(Business Wire)-November 17, 2008 -
Altus Pharmaceuticals Reaffirms Plan to Submit New Drug Application for Trizytek Approval
WALTHAM, Mass.-(Business Wire)-November 17, 2008 -
Richard Hollis, Chairman, President and CEO of Hollis-Eden Pharmaceuticals Talks to The Wall Street Transcript
NEW YORK-(Business Wire)-November 17, 2008 -
University General Hospital First in Nation to Utilize Excelyte™ as Primary Disinfectant
HOUSTON-(Business Wire)-November 17, 2008 -
HepaLife™ Patented ‘PICM-19’ Liver Stem Cell Line Launched Onboard Space Shuttle “Endeavour”
BOSTON-(Business Wire)-November 17, 2008 -
Never Forget to Take Medication Again: Vitality GlowCaps Now Available on Amazon.com
BOSTON-(Business Wire)-November 17, 2008 -
GeneLink Reports Record Third Quarter Results, Revenues Exceed $1.8M
ORLANDO, Fla.-(Business Wire)-November 17, 2008 -
InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery
BILTHOVEN, The Netherlands & DRESDEN, Germany-(Business Wire)-November 17, 2008 -
Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval
CAMBRIDGE, Mass.-(Business Wire)-November 17, 2008 -
Cook Medical Unveils Web Site Designed to Educate Physicians on Balloon Percutaneous Tracheostomy
BLOOMINGTON, Ind.-(Business Wire)-November 17, 2008 -
Convey Computer™ Corporation Announces First Customer: University of California, San Diego
AUSTIN, Texas-(Business Wire)-November 17, 2008 -
Nutra Pharma Announces Provision of RPI-78M under Compassionate Release to Adrenomyeloneuropathy (AMN) Patients
BOCA RATON, Fla.-(Business Wire)-November 17, 2008 -
Meridian Bioscience to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
CINCINNATI-(Business Wire)-November 17, 2008 -
Alkermes Presents Positive Preclinical Data on Novel, Proprietary Molecule Designed to Improve Outcomes for Patients Taking Opioid Analgesics
CAMBRIDGE, Mass.-(Business Wire)-November 17, 2008 -
RegeneRx’s Experimental Drug Promotes Healing in Patients With Non-Healing Corneal Ulcers
BETHESDA, Md.-(Business Wire)-November 17, 2008 -
Utah CEOs Discuss the Must-Haves for a High-Growth Company
PLEASANT GROVE, Utah-(Business Wire)-November 17, 2008 -
Cenomed BioSciences Presents Data on New Drug Candidates at the Society for Neuroscience in Washington DC
IRVINE, Calif.-(Business Wire)-November 17, 2008 -
Dr. Blair Keagy Launches MPAnalytics, Inc. Medical Consultant Group
CHAPEL HILL, N.C.-(Business Wire)-November 17, 2008 - Blair Keagy, MD, CEO, is pleased to announce the launch of MPAnalytics, Inc. - a medical consultant group dedicated to helping businesses evaluate the commercial potential of new medical products and technologies. MPAnalytics provides market...
Wall Street Analyst Forum 2008 Presenter Profiles
NEW YORK-(Business Wire)-November 17, 2008 -
PerkinElmer Launches Volocity 5(R) High Performance Imaging Acquisition and Analysis Software
WASHINGTON-(Business Wire)-November 17, 2008 -
BioSante Pharmaceuticals Announces Receipt of NIH Grant for Inhaled Interferon
LINCOLNSHIRE, Ill.-(Business Wire)-November 17, 2008 -
St. Jude Medical Announces Japanese Approval and Launch of Victory Family of Pacemakers
ST. PAUL, Minn.-(Business Wire)-November 17, 2008 -
Progenics Announces Wyeth Has Received RELISTOR Approval in Australia
TARRYTOWN, N.Y.-(Business Wire)-November 17, 2008 -
Rexahn Pharmaceuticals Strengthens Clinical Development Leadership with Formation of Oncology Scientific Advisory Board
ROCKVILLE, Md.-(Business Wire)-November 17, 2008 -
Provectus Pharmaceuticals Adds Sixth Center to Phase 2 Clinical Trial of PV-10
KNOXVILLE, Tenn.-(Business Wire)-November 17, 2008 -
Life Science Pharmaceuticals Enters Into Agreement with Abbott to Develop Antibody 806
GREENWICH, Conn.-(Business Wire)-November 17, 2008 -
Medtronic Adds Innovative Bone Cement Delivery System to Its Spine Product Portfolio
MINNEAPOLIS-(Business Wire)-November 17, 2008 -
Sequenom Completes Acquisition of CLIA-Certified Laboratory
SAN DIEGO-(Business Wire)-November 17, 2008 -
APR Applied Pharma Research and Fidia Farmaceutici Receive IND Approval from FDA for a New NSAID Matrix Patch Product
BALERNA, Switzerland & ABANO TERME (PD), Italy-(Business Wire)-November 17, 2008 -
ZIOPHARM Oncology Presents Positive Data from Studies of Palifosfamide
LONDON-(Business Wire)-November 17, 2008 -
Broad Institute of MIT and Harvard Ramps Up Cancer Research by Expanding Its Fleet of SOLiD™ Systems From Applied Biosystems
FOSTER CITY, Calif.-(Business Wire)-November 17, 2008 -
BioScopix, a wholly owned subsidiary of Mediscience, acquires SensiVida Medical Systems; Merged entity to be named SensiVida Medical Technologies, Inc; Strong management, CEO-CTO team, takes helm
CHERRY HILL, N.J.-(Business Wire)-November 17, 2008 -
Ascent Therapeutics Debuts with the Appointment of CEO and Head of Discovery Research
CAMBRIDGE, Mass.-(Business Wire)-November 17, 2008 -
CPEX Pharmaceuticals Announces Initiation of Phase II Trial for Urology Indication by Serenity Pharmaceuticals
EXETER, N.H.-(Business Wire)-November 17, 2008 -
Covidien Reports Fourth-Quarter and Fiscal 2008 Results
HAMILTON, Bermuda-(Business Wire)-November 17, 2008 - Covidien Ltd. (NYSE: COV; BSX: COV) today reported results for the fourth quarter of fiscal 2008 (July - September 2008). Fourth-quarter net sales rose 12% to $2.6 billion from $2.3 billion a year ago, fueled by strong growth in the Medical...
Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7%
SAN DIEGO-(Business Wire)-November 17, 2008 -
Roche, Merck Serono and Abbott Join Forces in Biotechnology Cluster Rhine-Neckar (BioRN)
MANNHEIM, Germany-(Business Wire)-November 17, 2008 -
Biothera Expertise in Carbohydrate Characterization Highlighted
EAGAN, Minn.-(Business Wire)-November 17, 2008 -
Midatech forms PharMida AG, a New Life Science Subsidiary Applying Nanotechnology to Drug Discovery and Development
OXFORD, England-(Business Wire)-November 17, 2008 -
HBIO Appoints McNaughton New CFO
HOLLISTON, Mass.-(Business Wire)-November 14, 2008 - Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, today announced the hiring and appointment of Thomas McNaughton as its new Chief Financial...
ARYx Therapeutics Presents Clinical Data for ATI-5923 at American Heart Association Scientific Sessions 2008
NEW ORLEANS-(Business Wire)-November 14, 2008 - ARYx Therapeutics (NASDAQ:ARYX) announced today that clinical data for ATI-5923, a novel vitamin K epoxide reductase (VKOR) inhibitor in Phase 2/3 development for the treatment of patients at risk of forming dangerous blood clots, were presented this...
Dynavax Announces Receipt of Notice of Failure to Satisfy a Continued Listing Rule from The Nasdaq Global Market
BERKELEY, Calif.-(Business Wire)-November 14, 2008 - Dynavax Technologies Corporation (NASDAQ:DVAX) announced today that on November 10, 2008, the Company received a notice from The Nasdaq Stock Market indicating that the Company is not in compliance with the continued listing requirements of The...
Gilead Sciences Announces Notification of ANDA Filing for Truvada
FOSTER CITY, Calif.-(Business Wire)-November 14, 2008 - Gilead Sciences, Inc. (Nasdaq:GILD) today announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA...
Microfluidics International Corporation to Report Third Quarter 2008 Financial Results on November 18, 2008
NEWTON, Mass.-(Business Wire)-November 14, 2008 - Microfluidics International Corporation (OTCBB: MFLU) announced today that the Company will release third quarter 2008 financial results on Tuesday, November 18, 2008, before the opening of the U.S. financial markets. Michael C. Ferrara, President...
VERIDIEN Updates 2008 Revenue Projections
LARGO, Fla.-(Business Wire)-November 14, 2008 - Veridien Corporation (OTCBB:VRDE) announced today that it is updating previously reported Revenue estimates. As a result of (i) two anticipated major private label contract orders that did not materialize (one where the company had firm projections...
Luminex Corporation Announces First Commercial Shipment of FLEXMAP 3D Systems
AUSTIN, Texas-(Business Wire)-November 14, 2008 - Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced the commercial sale and shipment of the first FLEXMAP(TM) 3D system manufactured in Austin, Texas. Full market release of the instrument is expected in...
Biogen Idec to Present at the Lazard Capital Markets Fifth Annual Life Sciences Conference
CAMBRIDGE, Mass.-(Business Wire)-November 14, 2008 - Biogen Idec Inc. (NASDAQ/BIIB) announced today that its presentation at the Lazard Capital Markets Fifth Annual Life Sciences Conference will be webcast live via the internet, on Wednesday, November 19th, 2008 at 11:00 a.m. ET. To access the...
Nanogen to Host Third Quarter Conference Call November 17, 2008
SAN DIEGO-(Business Wire)-November 14, 2008 - Nanogen, Inc. (Nasdaq:NGEN), developer of innovative, high-quality diagnostic products, will host a conference call on Monday, November 17, 2008 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to discuss 2008 third quarter results. The financial results press...
BIO-Europe 2008 Exhibitor and Presenter Profiles
MANNHEIM, Germany-(Business Wire)-November 14, 2008 - BIO-Europe 2008 takes place November 17, 2008 - November 19, 2008 at the Congress Center Mannheim in Mannheim. Listed below are the BIO-Europe 2008 exhibitor and presenter profiles. For in-depth information about the event, visit...
AnaSpec Establishes New Dedicated GMP Manufacturing Facility
SAN JOSE, Calif.-(Business Wire)-November 14, 2008 - In response to increased demand for GMP peptide production, AnaSpec has established a new facility dedicated to GMP manufacturing. Located adjacent to its current San Jose, California-based headquarters, the expansion provides an additional 5000...
Neurologix Announces Third Quarter 2008 Financial Results
FORT LEE, N.J.-(Business Wire)-November 14, 2008 - Neurologix, Inc. (OTCBB:NRGX), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today its financial results for the third quarter and nine months ended September...
Nymox Reports Third Quarter 2008 Financial Results
HASBROUCK HEIGHTS, N.J.-(Business Wire)-November 14, 2008 - Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today its financial results for the third quarter of 2008. Nymox reported a net loss of $1,350,536, or $0.05 per share for the quarter ending September 30, 2008, compared to...
NovaBay Pharmaceuticals (NBY) Reports Third Quarter 2008 Financial Results
EMERYVILLE, Calif.-(Business Wire)-November 14, 2008 - NovaBay Pharmaceuticals, Inc. (AMEX: NBY; TSX: NBY, http://www.novabaypharma.com), a clinical stage company developing non-antibiotic anti-infective compounds that do not develop resistance, for the treatment or prevention of a wide range of...
Vertex Pharmaceuticals Announces Webcast of its Presentation at Two Investor Conferences
CAMBRIDGE, Mass.-(Business Wire)-November 14, 2008 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the Lazard Capital Markets Healthcare Conference on Wednesday, November 19, 2008 at 2:30 p.m. EST and at the Needham &...
Helicos Launches Open Access Web Site With Microbial Genome Data
CAMBRIDGE, Mass.-(Business Wire)-November 14, 2008 - Helicos BioSciences Corporation (NASDAQ:HLCS) today announced the launch of the HeliSphere(TM) Technology Center, an open access Web site Genetic Analysis System; competition; changing technology and customer requirements; our ability to...
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2008
WORCESTER, Mass.-(Business Wire)-November 14, 2008 - RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported results for the quarter ended September 30...
Unigene Laboratories, Inc. Joins Scrip World's Biotechnology Top Fifty
FAIRFIELD, N.J.-(Business Wire)-November 14, 2008 - Unigene Laboratories, Inc. (OTCBB: UGNE, http:// www.unigene.com), a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs, has been included in the Scrip World Pharmaceutical News "Company League Tables...
ArQule, Inc. to Present at Lazard Capital Markets Healthcare Conference
WOBURN, Mass.-(Business Wire)-November 14, 2008 - ArQule, Inc. (Nasdaq: ARQL) today announced that the Company will present at the Lazard Capital Markets Healthcare Conference on November 19, 2008, at 3:00 PM eastern time. The presentation will be web cast live and may be accessed through the...
Search Our News Using Google Search
Can't find what you want? Try using Google:
